Main

Substantial evidence from epidemiologic data and experimental animal models indicate that stressful conditions during intrauterine fetal life affect behavioral development and future health of the offspring. Maladaptation of the fetal autonomic regulation has been suggested as a putative predisposing factor in the pathogenesis of cardiovascular, metabolic, and psychiatric diseases in low birth weight (LBW) infants (13). This has been reinforced by the discovery of an early programming of the stress response–mediating neuroendocrine system, namely the hypothalamic-pituitary-adrenal (HPA) axis and the autonomic nervous system (4,5). As such, LBW, a surrogate for fetal malnutrition has been linked with increased adrenocortical hormone activity and activation of the sympathetic nervous system (69) in childhood and adult life in independent populations.

A pathophysiologic explanation of this phenomenon described by Barker's group as “fetal programming” (10) has been derived from animal models revealing long-term changes in the molecular expression of steroid receptors within the limbic system (11).

Increases in glucocorticoids, such as cortisol and cortisone, are generally considered as adaptive mechanisms to mobilize energy for survival in response to a stressful event or to danger (12). Prolonged intrauterine exposure to stress, however, may lead to an alteration of the set point of the stress regulatory system resulting in increased levels of cortisol that can negatively effect the functioning of several biologic systems (13,14) and ultimately result in arterial hypertension and diabetes mellitus type II, one of the main risk factors for arteriosclerosis-associated diseases.

Because patterns of stress response in early postnatal life may help to identify prenatally induced alterations in the HPA axis and simultaneously exclude an only temporarily activated HPA axis due to adverse intrauterine conditions, we analyzed the stress reactivity of the HPA axis in small for gestational age (SGA) newborns. Our results provide evidence that the HPA axis is already altered in SGA newborns and may, if these alterations persist permanently, play a role in the intrauterine origin of adult diseases.

MATERIALS AND METHODS

Subjects.

The study was approved by the Research Ethics Committee of the University of Zurich and the Federal Ethics Commission of the Canton of Zurich. Written maternal consent was obtained from all participants in the study.

Saliva samples from 40 appropriate for gestational age (AGA) and 18 SGA infants were analyzed. Approximately, 40 SGA infants after 34 wk of gestation were born during the study period (April–September, 2005) in our hospital with 2300 deliveries per year. Healthy controls were recruited until approximately the double number of study patients was reached to obtain adequate numbers for statistical evaluation. SGA was defined as birth weight below the 5th percentile of the gender-specific newborn reference chart (15). Birth weight between the 10th and 90th percentile was required for AGA children. Only healthy newborns delivered after 34 wk of gestation (≥238 d) were included in the study. Newborns requiring intensive care or those with malformations were excluded from the study. Additional exclusion criteria included maternal substance abuse (nicotine, alcohol) and exogenous corticosteroid treatment (e.g., for lung maturation induction) during pregnancy. Sonographic measurements of fetal crown-rump length and biparietal diameter during the first trimester served as parameters for accurate determination of gestational age. In the SGA group, 10 infants had a diagnosis of intrauterine growth restriction (IUGR) established either by serial sonographic biometry or by pathologic Doppler measurements, one was SGA alone and 7 infants were referred to our clinic for delivery only and did not receive antenatal care at our institution. Sonographic data for the latter group were not available.

Experimental procedures.

Salivary cortisol and cortisone levels were collected between 72 and 96 h postnatal during a routine heel prick for the Guthrie test (a newborn screening test for metabolic disorders). This was considered to be the equivalent of a stress event. Although infants are born without a circardian rhythm and acquire it only within the first year of life (16), saliva samples were collected only during the morning hours between 8 a.m. and 1 p.m. from each infant 10 min before and 20 min after the stress event. Baseline levels were obtained in an undisturbed environment. The time of collection was based on experiments revealing peak cortisol responses between 20 and 30 min postmanipulation (17). To obtain the saliva, a cotton swab was placed in the infants' mouth for a duration of 5 min. Salivary cortisol reflects the unbound, active fraction of cortisol and is highly correlated with plasma cortisol levels (18,19). Samples were placed in saliva collection tubes (Salivette, Sarstedt, Nümbrecht, Germany) and frozen at −20°C until further analysis.

Cortisol/cortisone measurements.

Saliva cortisol and cortisone were determined simultaneously using liquid chromatography tandem mass spectrometry, with atmospheric pressure chemical ionization in the positive ion mode, according to a modified method of Rauh et al. (20). One hundred microliters of the samples and calibrators were deproteinized with methanol/zinc sulfate (50 g/L, 1/1 vol/vol). After centrifugation, the supernatants were applied to an online solid-phase extraction column with subsequent high-performance liquid chromatography separation using column switching (extraction column: Oasis HLB 2.1 × 20 mm, 15 μm; Waters, Milford, MA). The samples were washed with 5% methanol and eluted in back-flush with 2 mM ammonium acetate/methanol (30:70, vol/vol) onto the analytical column (Chromolith RP 18e100 × 4.6 mm, Merck, Darmstadt, Germany) at a flow rate of 1 mL/min. Sample analysis was performed in the multiple-reaction monitoring mode with a dwell time of 150 ms per channel using the following transitions for quantification (qualifier transition): m/z 363.2/121.2 (363.2/309.4) cortisol, m/z 361.1/162.9 (361.1/239.0) cortisone, m/z 367.3/121.2 Cortisol-d4.

Statistical analysis.

We applied STATA 9 Statistics/Data Analysis Software (Stata Corporation, College Station, TX) for statistical analysis according to Altman's recommendations for repeated measurements (21). Baseline characteristics of SGA and AGA infants were compared using the Mann–Whitney test and χ2 test when appropriate. Because basal levels of cortisol vary considerably in individual newborns and children (17), absolute values and relative alterations were analyzed. Cortisol and cortisone values were not normally distributed as analyzed by the Shapiro-Francia W' test. We therefore analyzed the difference between cortisol and cortisone baseline levels and time point “20 min post” using the Wilcoxon signed rank test. The Mann–Whitney test was used for comparison of raw baseline cortisol and cortisone levels. A stepwise multiple regression was applied to test for putative influencing factors on cortisol alterations such as gestational age, birth weight independent of gestational age, mode of delivery (vaginal/cesarean section), and gender. To validate our statistical analyses, a power calculation was conducted in SGA infants assuming the mean increase in cortisol levels of AGA infants as relevant. Finally, cortisol and cortisone levels in AGA and SGA infants were tested for correlation using the Spearman rank correlation test. The level of statistical significance of all analyses was set at p < 0.05.

RESULTS

The gestational ages of the AGA and SGA newborns were comparable (median: 273 versus 266 d of gestation, respectively, p = 0.29). Median birth weight of the SGA children was 2265 g corresponding to the 1.6th weight percentile compared with 3288 g corresponding to the 52nd percentile in the AGA group. A summary of the characteristics of the study population is given in Table 1.

Table 1 Baseline characteristics

Median levels for basal cortisol and cortisone were comparable in the AGA and SGA neonates (1.18 versus 0.95 ng/mL, p = 0.7; 11.35 versus 13.55 ng/mL, p = 0.42, respectively). Individual stress responses are illustrated in Figure 1a and b. In AGA neonates, salivary levels of cortisol and cortisone significantly increased after the stress stimulus (2.4 and 18.15 ng/mL, p < 0.05, respectively). In contrast, the cortisol and cortisone response in SGA neonates was noticeably blunted (0.69 ng/mL, p = 0.76 and 13.05 ng/mL, p = 0.65, respectively) (Fig. 2a and b). To validate the absent cortisol response in SGA neonates a one-sample t test power calculation was conducted for the given sample size (n = 18) revealing a power of 99% at a significance level of 0.05.

Figure 1
figure 1

Salivary absolute levels for cortisol (a) and cortisone (b) including individual courses of AGA (n = 40) and SGA (n = 18) newborns before (baseline) and after (20 min post) application of the stress stimulus.

Figure 2
figure 2

Mean relative salivary level alterations for cortisol (a) and cortisone (b) and SEM. In AGA newborns (n = 40), cortisol and cortisone levels significantly increase after stress induction (p < 0.05). In SGA newborns (n = 18), cortisol and cortisone levels do not significantly increase after application of the stress stimulus (p = 0.76, p = 0.65, respectively).

To test for a putative influence of gestational age, gender, birth weight, and mode of delivery on cortisol stress response patterns a multiple stepwise regression model was applied. None of these factors were found to have a significant influence (p = 0.574, p = 0.207, p = 0.347, p = 0.927, respectively, Table 2).

Table 2 Multiple stepwise regression model

Finally, a Spearman rank correlation revealed a strong correlation for cortisol and cortisone levels in AGA (R = 0.77, p < 0.001) and in SGA (R = 0.82, p < 0.001) neonates, thus excluding the possibility that decreased cortisol responses in SGA neonates could be the result of an increased conversion of cortisol to cortisone (22).

DISCUSSION

We have shown that the hypothalamic-pituitary-adrenal (HPA) axis system of SGA neonates does not adequately react in response to the application of a stress stimulus. Experiments in fetal sheep showed that the cortisol responses to acute stresses are often blunted during suboptimal intrauterine conditions in late gestation (23). In the presence of adverse intrauterine conditions, decreases in the mRNA content of hypothalamic corticotrophin-releasing hormone, pituitary glucocorticoid receptor, and adrenal ACTH (ACTH) receptor have been found (11), which will impair feedback regulation of the axis. These observations suggest that adverse intrauterine conditions alter both the set point and sensitivity of the fetal HPA axis. Alterations of the HPA axis activity in human adults born SGA have been reported repeatedly. Thus, birth weight has been shown to be inversely correlated with basal cortisol levels in independent populations (9). Furthermore, cortisol responses to pharmacological ACTH challenge (24,25) and after psychosocial stress (26) were exaggerated in adults born with LBW. Others, however, did not find a clear inverse correlation between birth weight and HPA activity (27). These inconsistent results may reflect large heterogeneities in the populations studied, often a mixture of premature infants, infants with uncertain gestational ages, LBW fetuses, fetuses with IUGR as well as different experimental settings.

Although the majority of studies in humans provide strong evidence for an alteration of the HPA axis set point and feedback in adults born SGA, these findings do not necessarily represent etiologic factors involved in the concept of fetal programming especially considering the interdependence of the pituitary-adrenocortical response with other neuroendocrine regulatory systems. Moreover, the influence of environmental factors on alterations of the HPA system remains unknown, because this factor was not controlled in most of the above-mentioned studies. To elucidate a putative intrauterine induction of permanent alteration of the HPA-axis system balance, we focused on HPA-axis activity and development in the early postnatal period. In our study, we were able to demonstrate that the stress response is altered in SGA neonates on the 4th day of life. It is difficult to exactly define an adverse intrauterine environment for the fetus. Fetuses with IUGR are not necessarily SGA and the definition of IUGR varies considerably in the literature. The definition of SGA is unequivocal and is commonly referred to as a weight below the 10th percentile for gestational age. If the definition threshold is set low and fetuses with aneuploidies and infections are excluded, a relatively homogenous population of fetuses experiencing adverse intrauterine conditions is left. In our study, we adopted a threshold for SGA definition as birth weight below the 5th percentile. The median birth weight of the SGA newborns in our study corresponds to the 1.6th percentile defining a relatively homogeneous cohort of growth-restricted neonates. The majority of epidemiologic studies have correlated just LBW with the risk for hypertension (28). One may expect an even more pronounced effect if only infants with proven intrauterine compromise could have been included in these studies.

A strength of our study population is that, in contrast to most studies, maternal influencing factors, such as nicotine and alcohol consumption during pregnancy, and antenatal corticosteroid administration that have been shown to induce growth restriction, but may at the same time have independent effects on the HPA axis of the mother and child (2934), have all been excluded in our study.

The heel-prick test has been shown to be a significant stress event for the newborn, resulting in HPA axis activation as indicated by significantly increasing cortisol levels in response to the test (35). We found a wide variation in cortisol levels between individual infants. This variation has been observed in other studies as well. Nonetheless, variations over time in the same individual have not been shown to vary significantly (17,36).

Few studies analyzed the activity of the human HPA axis in the adolescent and perinatal period. In SGA children, increased plasma and urinary glucocorticoid levels were found at the age of 9 yr (37), others, however, did not observe a correlation between basal serum cortisol levels and rhythms during a 24-h period in 8–10-y-old children born SGA (38).

To our knowledge, the present study is the first to analyze HPA reactivity in healthy human SGA neonates. Experiments in neonates provide the possibility to study the persistence of intrauterine-induced alteration of the HPA axis into the postnatal period and to differentiate them from changes, which are only transiently altered as a compensatory mechanism during intrauterine undernutrition. At the same time, long-term effects resulting from these primary alterations do not yet have the time to develop. Furthermore, the neonatal period may represent an intermediate stage of HPA axis development still susceptible to plastic changes.

The absent stress response in SGA neonates in our study was rather surprising. A delay in the maturation of the HPA system as a possible explanation is rather unlikely, because premature AGA newborns at 34 wk of gestation already display normal stress reactivity (31). Furthermore, maturation of cerebral structures in SGA fetuses is considered to be rather accelerated (39).

Interestingly, children seem to show reduced cortisol responses to stress factors during the first year of life (40,41), which seems to be a stress hyposensitive period. The absent response to stress induction in our SGA population may therefore reflect an accelerated HPA system maturation in comparison to AGA infants accounting for inadequate time for proper establishment of important developmental steps.

Growth-restricted preterm infants (<32 wk of gestation) seem to have a lower steroidogenic capacity than infants with uninhibited fetal growth in response to ACTH stimulation leading to an insufficient response to stress (42). This may be related to enzyme deficiencies in the adrenal cortex (43). However, ACTH stimulation cannot differentiate adrenal and pituitary causes of a diminished response.

Stress hyposensitive periods at different stages of postnatal development have been observed in animals as well (44). Blunted cortisol responses to ACTH and acute stressors have been observed in fetal sheep during chronic unfavorable intrauterine conditions (23,45). These observations are consistent with changes on the molecular level reflected by alterations in various hypothalamic receptor expression levels (11), resulting in reduced HPA sensitivity. Considering these data, intrauterine fetal stress because of undernutrition may lead to a hyporeactivity of the HPA system to stressors in early life, but seems to be modified by postnatal factors. If this notion could be confirmed, HPA system plasticity during early life would provide the chance to therapeutically influence the system. Indeed, influencing the HPA system in the postnatal period has been shown to be possible at least in animals (46).

It was suggested that mode of delivery may influence infant HPA axis response in response to different stress levels for up to 2 months of age (47) even though in a larger population this finding was less clear (48). Saliva samples in our study were obtained during the 4th day of life after stabilization of birth-related fluctuations (49). According to a multiple stepwise regression model, mode of delivery does not seem to have an influence on the HPA axis response at least in our collective. Furthermore, there is evidence from animal models that females might be more sensitive to HPA axis programming than males (50,51). However, we did not find a gender difference in HPA axis reactivity in our study. Associations between LBW and increased HPA axis activation have also not been found to be different in adult men and women (52), thereby confirming our results. It seems that gender-specific cortisol reactivity in general depends on different levels of corticosteroid-binding globulin and sex steroids (53). We therefore cannot exclude gender-specific hormonal influences that may manifest during adolescence and adulthood in SGA infants.

Our data only provide a glimpse of HPA axis alteration in the SGA neonate. We do not know whether these alterations persist or how they change during life. Nevertheless, they represent a prerequisite if intrauterine conditions per se are to play a role in the etiology of adult diseases. Prospective long-term investigations over years are required to prove this hypothesis.

In conclusion, stress response in SGA infants seems to be abnormal beginning as early as the neonatal period. However, the characteristics of these abnormalities are changing constantly during the course of life. Apparently, a hyporeactive HPA axis system in early life is converted to a hyper-reactive system, both being unfavorable. The exact mechanisms responsible for these alterations are still elusive. The apparent plasticity of the system provides hope that therapeutic reprogramming of this system may be a realistic long-term objective.